Submitted by Anonymous (not verified) on 30 March 2026 - 15:58
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Date of authorisation: 30/06/2025, Revision: 3, Status: Authorised
Source: